CMA vs GUTS
CMA (CMA) versus Fractyl Health, Inc. Common Stock (GUTS) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Fractyl Health, Inc. Common Stock (GUTS) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported GUTS revenue for 2025-12-31 was $0. Net income was -$141.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. GUTS currently screens at market cap $74.9M.
GUTS currently screens at market cap $74.9M.
Not investment advice. Open the CMA and GUTS stock pages for the full models.
Not investment advice.